Novo Nordisk: This country approves Ozempic to reduce risk of kidney disease in diabetes patients | – The Times of India
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk…
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk…
